(Q49089912)

18 February 2018

title

Severe forms of neurocysticercosis: treatment with albendazole. (English)

1 reference

18 February 2018

1 reference

Agapejev S

1

1 reference

18 February 2018

Da Silva MD

series ordinal

2

1 reference

18 February 2018

Ueda AK

series ordinal

3

1 reference

18 February 2018

publication date

1 March 1996

1 reference

18 February 2018

Arquivos de Neuro-Psiquiatria

published in

1 reference

18 February 2018

volume

54

1 reference

18 February 2018

issue

1

1 reference

18 February 2018

page(s)

82-93

1 reference

18 February 2018

Cysticercosis of the central nervous system. I. Surgical treatment of cerebral cysticercosis: a 23 years experience in the Hospital das Clínicas of Ribeirão Preto Medical School

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

Albendazole therapy for subarachnoid and ventricular cysticercosis. Case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

Albendazole therapy for giant subarachnoid cysticerci

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

A prognostic classification of cerebral cysticercosis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

Hydrocephalus in cerebral cysticercosis. Pathogenic and therapeutic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

Diffusion of intramuscular ketoprofen into the cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

Differential diagnosis between ventriculitis and fourth ventricle cyst in neurocysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

[Cerebrospinal fluid syndrome induced by neurocysticercosis.]

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

Therapy for neurocysticercosis. Comparison between albendazole and praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

Cysticercosis of the central nervous system: clinical and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

Selective indications for the use of praziquantel in the treatment of brain cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

The course of seizures after treatment for cerebral cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X1996000100014

10.1590/S0004-282X1996000100014

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

8736150

1 reference

18 February 2018